The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

FDA Decisions to Watch in Q4 2024 thumbnail
5 FDA Decisions to Watch in Q4 2024

October 4th 2024

A review of 5 highly anticipated FDA decisions expected by year-end, including acoramidis for ATTR-CM, olezarsen for FCS, sotagliflozin for T1D and CKD, and more.

TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency| Image Credit: US Food and Drug Administration
TransCon hGH Aims for FDA Label Expansion for Adult Growth Hormone Deficiency

September 30th 2024

Shane Bobart, MD | Credit: Houston Methodist
Study Reveals Factors Associated with Non-DKD on Kidney Biopsy in Patients with Diabetes

September 26th 2024

Ertugliflozin Lowers UA, Improves Gout Outcomes in People With Type 2 Diabetes and ASCVD
Ertugliflozin Lowers UA, Improves Gout Outcomes in People With Type 2 Diabetes and ASCVD

September 26th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Eversense 365, Marking First 1-Year CGM Option in Diabetes

September 18th 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.